Kim and colleagues showed that IL-22 induces S1PR1 and IL22R1 expression in myeloid cells and macrophages, and induce MCP1 expression in myeloid stem cells (MSCs), and then facilitate macrophage infiltration, implying a potential effect of IL-22 on promoting bone metastasis of breast cancers via IL22R1/S1PR1 pathway [158]. This evidence concerns the gene S1PR1 and breast carcinoma.